Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

123
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
123
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

115
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
115
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

171
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
171
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

89
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
89
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

122
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
122
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

1.2K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rivaroxaban for the prevention of atherothrombotic events in advanced CKD: are we off TRACK?

Clinical kidney journal·2026
Same author

Drug prescription for patients treated by dialysis: navigation in the fog.

Clinical kidney journal·2026
Same author

Liver fraction of circulating alkaline phosphatase is elevated in chronic kidney disease and associates with mortality in patients treated with haemodialysis.

Clinical kidney journal·2026
Same author

Kidney Function Modulates Gut Microbial Metabolism.

Toxins·2026
Same author

Intestinal Barrier Dysfunction in Chronic Kidney Disease: Evidence, Mechanisms, and its Potential Clinical Implications.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same author

Hemoadsorption Combined with Hemodialysis (HAHD): a Consensus Statement from an International Expert Panel.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026

Related Experiment Video

Updated: Sep 26, 2025

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

21.0K

The Evolving View of Uremic Toxicity.

Bjorn Meijers1,2, Jerome Lowenstein3

  • 1Nephrology and Transplantation Unit, University Hospitals Leuven, 30000 Leuven, Belgium.

Toxins
|April 21, 2022
PubMed
Summary

Indoxyl sulfate, a protein-bound toxin, accumulates in kidney disease and accelerates renal damage. New findings suggest it acts as a systemic signaling molecule beyond the kidneys.

Keywords:
organic anion transporterprotein-bound soluteuremia

More Related Videos

An Immature Murine Model of Reversible Unilateral Ureteral Obstruction
06:37

An Immature Murine Model of Reversible Unilateral Ureteral Obstruction

Published on: April 4, 2025

354
Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
11:47

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes

Published on: March 4, 2022

2.4K

Related Experiment Videos

Last Updated: Sep 26, 2025

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

21.0K
An Immature Murine Model of Reversible Unilateral Ureteral Obstruction
06:37

An Immature Murine Model of Reversible Unilateral Ureteral Obstruction

Published on: April 4, 2025

354
Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
11:47

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes

Published on: March 4, 2022

2.4K

Area of Science:

  • Nephrology
  • Toxicology
  • Biochemistry

Background:

  • Indoxyl sulfate is a protein-bound solute that increases in kidney disease.
  • Early research identified it as a renal toxin accelerating kidney damage.
  • Recent studies reveal organic anion transporters in non-renal tissues.

Purpose of the Study:

  • To re-evaluate the role of indoxyl sulfate in systemic signaling.
  • To explore indoxyl sulfate's function beyond renal excretion.

Main Methods:

  • Review of existing literature on indoxyl sulfate.
  • Analysis of studies on protein-bound solutes in renal impairment.
  • Examination of data on organic anion transporters in various tissues.

Main Results:

  • Indoxyl sulfate concentration is elevated in patients with impaired glomerular filtration.
  • Indoxyl sulfate accelerates renal damage in experimental models.
  • Organic anion transporters are present in multiple non-renal tissues, suggesting broader roles.

Conclusions:

  • Indoxyl sulfate is more than a renal toxin; it functions as a systemic signaling molecule.
  • Its presence in non-renal tissues indicates a role in broader physiological processes.
  • Further research is needed to understand the systemic signaling pathways involving indoxyl sulfate.